<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21872" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Follicular Thyroid Cancer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashorobi</surname>
            <given-names>Damilola</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lopez</surname>
            <given-names>Peter P.</given-names>
          </name>
          <aff>MSU</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Damilola Ashorobi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Peter Lopez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21872.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The thyroid gland functions to produce the thyroid hormone, which is needed by the body to carry out different metabolism. Follicles comprise the thyroid and are the functional and structural units of the gland. Thyroid cancer is one of the most common endocrine tumors and is classified as differentiated or undifferentiated. Differentiated cancers include papillary and follicular thyroid carcinoma, and undifferentiated types include medullary thyroid and anaplastic cancer. This activity reviews follicular thyroid cancer, describing the etiology, epidemiology, histology, evaluation, staging, and complications of follicular thyroid cancer and the role of interprofessional teams in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the typical presentation of a patient with follicular cancer.</p></list-item><list-item><p>Describe the typical evaluation findings associated with follicular cancer.</p></list-item><list-item><p>Explain the treatment options for patients with follicular cancer.</p></list-item><list-item><p>Review the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients with follicular cancer.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21872&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21872">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21872.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The thyroid is an endocrine gland located just below the cricoid cartilage in the neck, and it is composed of both the right and the left lobes separated by an isthmus. The thyroid gland functions to produce the thyroid hormone, which is needed by the body to carry out different metabolism. Follicles comprise the thyroid and are the functional and structural units of the gland.<xref ref-type="bibr" rid="article-21872.r1">[1]</xref> Epithelial cells line the follicles, which could be cuboidal or columnar, depending on the state of activity. These cells could develop abnormal growth causing follicular malignancy.&#x000a0;Thyroid cancer is one of the most common endocrine tumors and is classified as differentiated or undifferentiated.<xref ref-type="bibr" rid="article-21872.r2">[2]</xref> Differentiated cancers include papillary and follicular thyroid carcinoma, and undifferentiated types include medullary thyroid cancer and anaplastic cancer. Papillary thyroid cancer accounts for most varieties. Follicular thyroid cancer is the second most prevalent type, accounting for 10 to 15% of all thyroid cancer.<xref ref-type="bibr" rid="article-21872.r3">[3]</xref>&#x000a0;The undifferentiated types are rare when compared to the differentiated types.<xref ref-type="bibr" rid="article-21872.r4">[4]</xref></p>
        <p>Up to half of follicular carcinoma cases show RAS point mutations, while one-third may show PAX-PPAR-gamma rearrangements, and only 3% show both.<xref ref-type="bibr" rid="article-21872.r5">[5]</xref><xref ref-type="bibr" rid="article-21872.r6">[6]</xref>&#x000a0;Follicular thyroid cancer is a tumor&#x000a0;of the follicular cells that are cuboidal epithelial cells and have capsular and vascular invasive properties. Compared to follicular carcinoma, follicular adenoma is benign&#x000a0;and occurs more commonly with a ratio estimated to be 5 to 1.<xref ref-type="bibr" rid="article-21872.r7">[7]</xref>&#x000a0;This article will focus more on the follicular type of thyroid cancer, discussing the etiology, epidemiology, histology, evaluation, staging, and complications of follicular thyroid cancer.</p>
      </sec>
      <sec id="article-21872.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The cause of thyroid cancer has links to radiation exposure, iodine intake, diabetes, obesity, Hashimoto thyroiditis, exogenous estrogen use, and dietary choices.<xref ref-type="bibr" rid="article-21872.r2">[2]</xref>&#x000a0;After the 1986 Chornobyl explosion, many radiation-induced cancers&#x000a0;were observed, including thyroid cancer.<xref ref-type="bibr" rid="article-21872.r8">[8]</xref>&#x000a0;The position of the thyroid makes it an easy target for radiation exposure. The thyroid is very sensitive to radiation at a younger age, and after exposure, the relative risk of having cancer is estimated to persist for over 50 years.<xref ref-type="bibr" rid="article-21872.r9">[9]</xref>&#x000a0;Apart from nuclear radiation, individuals can also get exposure through X-rays and CT scans. The increased use of these imaging studies could lead to an increased incidence of thyroid cancer. There is a controversy on whether iodine excess or deficiency causes thyroid cancer.<xref ref-type="bibr" rid="article-21872.r10">[10]</xref></p>
        <p>In some studies, like the one reported by Knobel et al. in 2007, it was found that iodine intake was a predisposing factor for thyroid cancer<xref ref-type="bibr" rid="article-21872.r11">[11]</xref>. In another study by Fortner J.G et al., the observation was that iodine deficiency could lead to thyroid epithelial cell carcinomas<xref ref-type="bibr" rid="article-21872.r12">[12]</xref>. Diabetes and obesity also share links with the rise in thyroid cancer.<xref ref-type="bibr" rid="article-21872.r13">[13]</xref> Hashimoto thyroiditis has been reported to cause thyroid cancer as well, mostly believed because it leads to an increase in the production of pro-inflammatory cytokines and oxidative stress.<xref ref-type="bibr" rid="article-21872.r2">[2]</xref>&#x000a0;Diet choices play a significant role in the incidence of thyroid cancer. Foods such as cabbage, broccoli, cauliflower, chicken, pork, and poultry have been found to cause an increased incidence of thyroid cancer while vegetables such as persimmons and tangerines correlate negatively with thyroid cancer incidence.<xref ref-type="bibr" rid="article-21872.r14">[14]</xref>&#x000a0;Too much multivitamin use has been shown to cause an increased incidence of thyroid cancer due to iodine content.<xref ref-type="bibr" rid="article-21872.r14">[14]</xref>&#x000a0;High nitrate or nitrite-containing foods have also been shown to increase the incidence of thyroid cancer.</p>
        <p>Some occupations have been correlated with an increased incidence of thyroid cancer. Occupational&#x000a0;exposure to radiation, pesticides, and&#x000a0;working in the textile industry has also shown an increased association with thyroid cancer.<xref ref-type="bibr" rid="article-21872.r15">[15]</xref></p>
      </sec>
      <sec id="article-21872.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Thyroid cancer ranks as the ninth most common cancer and accounts for 3.8% of all new cancer cases in the United States.<xref ref-type="bibr" rid="article-21872.r16">[16]</xref>&#x000a0;In 2017, the number of new cases of thyroid cancer was projected to be 56,780, with females having a higher incidence compared to males.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;Follicular thyroid cancer is the second most common cause of thyroid cancer, and it accounts for 4% to 39% of all thyroid cancers.<xref ref-type="bibr" rid="article-21872.r18">[18]</xref>&#x000a0;Follicular thyroid cancer is more common in older females, with a female-to-male ratio of 3 to 1 and an average age of presentation at 60 years old.<xref ref-type="bibr" rid="article-21872.r7">[7]</xref>&#x000a0;</p>
        <p>Some studies report that follicular thyroid cancer incidence is approximately 10% in iodine-sufficient areas and 25 to 40% in areas of iodine deficiency.<xref ref-type="bibr" rid="article-21872.r7">[7]</xref>&#x000a0;In the United States, the incidence of follicular thyroid cancer has decreased due to the elimination of iodine deficiency.<xref ref-type="bibr" rid="article-21872.r7">[7]</xref><xref ref-type="bibr" rid="article-21872.r19">[19]</xref><xref ref-type="bibr" rid="article-21872.r7">[7]</xref></p>
      </sec>
      <sec id="article-21872.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with thyroid carcinoma might have an enlargement of the thyroid gland due to the presence of a nodule in either or both thyroid lobes. They can occasionally be symptomatic with either hypothyroid or hyperthyroid characteristics, but they are usually asymptomatic.&#x000a0;</p>
      </sec>
      <sec id="article-21872.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ultrasound imaging and ultrasound-guided fine needle aspiration or core biopsy are used to diagnose primary thyroid carcinoma. Ultrasound of primary thyroid cancer usually shows solid hypoechoic nodules with micro-calcification, poorly defined margins, and vascular patterns with the dominant intranodular flow, as opposed to perinodular.<xref ref-type="bibr" rid="article-21872.r20">[20]</xref>&#x000a0;CT and MRI imaging studies are used to evaluate extrathyroidal tumor extension but not for the thyroid nodule itself.<xref ref-type="bibr" rid="article-21872.r20">[20]</xref>&#x000a0;The samples received from fine needle aspiration or core biopsy are then viewed under the microscope for confirmation. Follicular thyroid carcinoma is diagnosed based on pathologic confirmation of follicular cells that do not have the nuclear atypia seen in papillary thyroid cancer, including capsular and vascular invasion. Therefore, the basis of evaluation is mainly the histological findings of the pathologist. Thyroid carcinoma is classified as being follicular if it is invasive and contains mainly follicles. Histologic findings have been reported to vary among pathologists, leading to controversy in the classification of follicular thyroid carcinoma.<xref ref-type="bibr" rid="article-21872.r21">[21]</xref>&#x000a0;See <bold>Image.</bold>&#x000a0;Metastatic&#x000a0;Follicular&#x000a0;Thyroid&#x000a0;Carcinoma, CT Scan.</p>
      </sec>
      <sec id="article-21872.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment and management of follicular thyroid carcinoma depend on the stage at presentation. Follicular thyroid carcinoma with minimally invasive characteristics is treated with thyroid lobectomy and isthmectomy <xref ref-type="bibr" rid="article-21872.r22">[22]</xref>, but for invasive follicular carcinoma, total thyroidectomy, radioiodine ablation, and thyrotropin suppressing medications are all recommended.<xref ref-type="bibr" rid="article-21872.r23">[23]</xref><xref ref-type="bibr" rid="article-21872.r24">[24]</xref>&#x000a0;A study reported a 2.1-fold increase in follicular thyroid cancer recurrence in those who did not undergo radioiodine ablation compared to those who did, which is why the standard treatment recommendation is total thyroidectomy followed by radioiodine radiation.<xref ref-type="bibr" rid="article-21872.r25">[25]</xref><xref ref-type="bibr" rid="article-21872.r26">[26]</xref>&#x000a0;</p>
        <p>For patients with metastasis to bones and soft tissues, either radiotherapy or chemotherapy, or both are indicated after the total thyroidectomy. Chemotherapy that has been reported to control tumor progression and prolong progression-free survival includes tyrosine kinase inhibitors such as sorafenib, lenvatinib, vandetanib, and cabozantinib.<xref ref-type="bibr" rid="article-21872.r27">[27]</xref>&#x000a0;Newer agents working through new pathways are also tested with some good responses.<xref ref-type="bibr" rid="article-21872.r28">[28]</xref>&#x000a0;Thyroglobulin levels are measured to monitor for recurrence.&#x000a0;</p>
      </sec>
      <sec id="article-21872.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis of follicular thyroid carcinoma includes a follicular variant of papillary thyroid carcinoma, papillary thyroid carcinoma, noninvasive follicular thyroid neoplasm with papillary-like nuclear features or NIFTP,&#x000a0;and follicular adenoma.<xref ref-type="bibr" rid="article-21872.r29">[29]</xref> There is a controversy with the pathologic diagnosis of follicular thyroid carcinoma, and identification could differ from one pathologist to the other. This controversy is due to two factors: the degree of nuclear atypia and the degree of capsular or vascular invasion.<xref ref-type="bibr" rid="article-21872.r21">[21]</xref><xref ref-type="bibr" rid="article-21872.r30">[30]</xref>&#x000a0;</p>
        <p>NIFTP is one of the newest categories added to the pathology description of thyroid cancer cases. It is now considered benign, so it is recommended to be treated as such.<xref ref-type="bibr" rid="article-21872.r31">[31]</xref><xref ref-type="bibr" rid="article-21872.r32">[32]</xref><xref ref-type="bibr" rid="article-21872.r33">[33]</xref>&#x000a0;Special criteria for ultrasound radiologic diagnosis are being developed for distinguishing malignant from benign lesions.<xref ref-type="bibr" rid="article-21872.r34">[34]</xref><xref ref-type="bibr" rid="article-21872.r35">[35]</xref><xref ref-type="bibr" rid="article-21872.r31">[31]</xref></p>
      </sec>
      <sec id="article-21872.s9" sec-type="Staging">
        <title>Staging</title>
        <p>The TNM staging system is used to classify differentiated thyroid carcinoma. The T describes the size of the tumor. Tx indicates that the primary tumor cannot be assessed, T0 means the tumor is not palpable, T1 means less than 1cm, T2 means the tumor is 1 to 4 cm, T3 indicates it is greater than 4 cm, and T4 means any tumor size with extrapyramidal invasion. The N signifies lymph node involvement. Nx signifies regional adenopathy is not assessable, N0 means no palpable cervical adenopathy, N1 means ipsilateral cervical adenopathy, N2 means contralateral or bilateral cervical adenopathy, and finally, N3 means fixed cervical nodes. M means metastasis, with M0 indicative of no distant metastasis, and M1 indicates distant metastasis. Follicular thyroid carcinoma is classified into stages from I through IV. Stage I under 45 years old is any T, N, and M0, and over 45 years old is T1, N0, M0; for stage II under 45 years old is any T, N, and M1, and over 45 years old is T2, N0, M0; stage III is described for over 45 years of age with T4, N0, M0, and stage IV is described with any T, N, M1.<xref ref-type="bibr" rid="article-21872.r18">[18]</xref></p>
      </sec>
      <sec id="article-21872.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The thyroid cancer death rate has remained steady despite the increase in incidence. It is one of the lowest mortality cancers in the United States.<xref ref-type="bibr" rid="article-21872.r36">[36]</xref> In 2017, an estimated 2010 death occurred due to thyroid cancer compared to more than 150,000 deaths from lung cancer.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;Follicular thyroid cancer has a worse prognosis compared to papillary thyroid cancer due to its higher incidence of distant metastasis and patients frequently presenting with more advanced-stage disease.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;</p>
        <p>Even though follicular thyroid cancers have distant metastasis, metastasis to lymph nodes is uncommon, and occurrence is estimated to be fewer than 10%.<xref ref-type="bibr" rid="article-21872.r37">[37]</xref>&#x000a0;On the other hand, some studies reported that there is no prognostic difference between follicular thyroid cancer and papillary thyroid cancer when controlling for factors such as age and sex.<xref ref-type="bibr" rid="article-21872.r21">[21]</xref><xref ref-type="bibr" rid="article-21872.r38">[38]</xref><xref ref-type="bibr" rid="article-21872.r39">[39]</xref>&#x000a0;</p>
        <p>The overall 10-year survival of follicular cancer depends on the level of invasiveness. For minimally invasive cancers, 10-year survival is reported to be 98%, and for invasive follicular cancer, it is 80%.<xref ref-type="bibr" rid="article-21872.r7">[7]</xref>&#x000a0;Some studies report that the survival rate ranges from 46% to 97%, depending on the degree of capsular or vascular invasion.<xref ref-type="bibr" rid="article-21872.r21">[21]</xref>&#x000a0;The mortality rate of follicular thyroid carcinoma ranges from 5 to 15%, and those with capsular invasive characteristics have an overall worse prognosis than those without invasion.<xref ref-type="bibr" rid="article-21872.r40">[40]</xref><xref ref-type="bibr" rid="article-21872.r41">[41]</xref></p>
      </sec>
      <sec id="article-21872.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most worrisome complication involved in follicular thyroid cancer is metastasis. Studies have reported metastases mostly to bones, lungs, and lymph nodes. In a study done by Parasmeswaran et al. (2017), they found that 42% of their subjects had metastasis to the bones, 33% to the lungs, and 8% to the lymph nodes.<xref ref-type="bibr" rid="article-21872.r3">[3]</xref>&#x000a0;The incidence of distance metastasis in follicular thyroid carcinoma is estimated to be 6 to 20%.<xref ref-type="bibr" rid="article-21872.r42">[42]</xref></p>
        <p>Other complications correlate with surgery. The external and recurrent laryngeal nerves are near the thyroid gland and can mistakenly get damaged during surgery or resected due to invasion.<xref ref-type="bibr" rid="article-21872.r43">[43]</xref>&#x000a0;This will cause hoarseness in the patient's voice. There are also reports of hematoma and keloid formation in some patients after the surgery.<xref ref-type="bibr" rid="article-21872.r43">[43]</xref></p>
        <p>Because the patient is undergoing total thyroidectomy, hypothyroidism will always develop, and patients will require thyroxine replacement therapy.&#x000a0;</p>
      </sec>
      <sec id="article-21872.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although the prognosis of thyroid cancer has been reported to be good compared to other forms of cancer, the mention of the word "cancer" will still be a concern for most patients. For instance, most patients will still opt for surgical thyroid removal even if they have non-invasive follicular thyroid cancer that can be followed due to its slow growth. Patients and their physicians must work together to decide the best treatment option.<xref ref-type="bibr" rid="article-21872.r4">[4]</xref> Knowledge gained by patients will enable them to make better decisions about their health.</p>
      </sec>
      <sec id="article-21872.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The incidence of thyroid cancer has increased over the past few decades, attributed to its overdiagnosis.<xref ref-type="bibr" rid="article-21872.r44">[44]</xref><xref ref-type="bibr" rid="article-21872.r45">[45]</xref>&#x000a0;As a result, in 2017, USPTF recommended against screening&#x000a0;for thyroid cancer with either neck palpation or ultrasound in asymptomatic patients.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;In 2015, the American thyroid association recommended active surveillance of low-risk thyroid carcinomas with serial ultrasound and that not all patients require surgery. Also,&#x000a0;the organization released guidelines in 2015, not to biopsy thyroid nodules that are less than 1 cm.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;</p>
        <p>Health providers, including clinicians&#x000a0;(MDs, DOs, NPs, and PAs) and other healthcare professionals (e.g., nurses and pharmacists), should operate as an interprofessional team. All interprofessional team members must coordinate their activities using open communication channels and maintain accurate and updated patient records. They should all be aware of these guidelines; this will prevent potential harm to patients from overtreatment of low-risk thyroid cancers and help appropriately treat&#x000a0;patients with high-risk diseases. Reportedly, the overall cost of thyroid cancer in 2019 was nearly 21 billion dollars due to surgery costs.<xref ref-type="bibr" rid="article-21872.r17">[17]</xref>&#x000a0;Not all thyroid neoplasms require surgery, and physicians should keep this in mind when managing patients who develop thyroid cancer.</p>
      </sec>
      <sec id="article-21872.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21872&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21872">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/follicular-thyroid-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21872">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21872/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21872">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21872.s15">
        <fig id="article-21872.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Metastatic Follicular Thyroid Carcinoma, CT Scan Yale Rosen, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/Main_Page">Public Domain</ext-link>, via Wikimedia Commons&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Metastatic_follicular_thyroid_carcinoma_-_CT_scan_-_Case_264_x8559838032x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21872.s16">
        <title>References</title>
        <ref id="article-21872.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Joung</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Sul</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Shong</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Morphological and Functional Changes in the Thyroid Follicles of the Aged Murine and Humans.</article-title>
            <source>J Pathol Transl Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-435</page-range>
            <pub-id pub-id-type="pmid">27737529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Review of Factors Related to the Thyroid Cancer Epidemic.</article-title>
            <source>Int J Endocrinol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>5308635</fpage>
            <pub-id pub-id-type="pmid">28555155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parameswaran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shulin Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Min En</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>NK</given-names>
              </name>
            </person-group>
            <article-title>Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>99</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-154</page-range>
            <pub-id pub-id-type="pmid">27659362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallner</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reyes-Gastelum</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Lubitz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hawley</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Haymart</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2021</year>
            <month>May</month>
            <day>13</day>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>e2402</fpage>
            <page-range>e2402-e2412</page-range>
            <pub-id pub-id-type="pmid">33687063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eberhardt</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Grebe</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>McIver</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reddi</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.</article-title>
            <source>Mol Cell Endocrinol</source>
            <year>2010</year>
            <month>May</month>
            <day>28</day>
            <volume>321</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-6</page-range>
            <pub-id pub-id-type="pmid">19883731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marotta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bifulco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vitale</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer.</article-title>
            <source>Cancers (Basel)</source>
            <year>2021</year>
            <month>Jul</month>
            <day>27</day>
            <volume>13</volume>
            <issue>15</issue>
            <pub-id pub-id-type="pmid">34359686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McHenry</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Phitayakorn</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Follicular adenoma and carcinoma of the thyroid gland.</article-title>
            <source>Oncologist</source>
            <year>2011</year>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>585</fpage>
            <page-range>585-93</page-range>
            <pub-id pub-id-type="pmid">21482585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Radiation carcinogenesis: lessons from Chernobyl.</article-title>
            <source>Oncogene</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>27 Suppl 2</volume>
            <fpage>S9</fpage>
            <page-range>S9-18</page-range>
            <pub-id pub-id-type="pmid">19956182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furukawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Preston</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Funamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yonehara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tokuoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Soda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozasa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mabuchi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.</article-title>
            <source>Int J Cancer</source>
            <year>2013</year>
            <month>Mar</month>
            <day>01</day>
            <volume>132</volume>
            <issue>5</issue>
            <fpage>1222</fpage>
            <page-range>1222-6</page-range>
            <pub-id pub-id-type="pmid">22847218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aceves</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mendieta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Anguiano</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Delgado-Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Jan</month>
            <day>27</day>
            <volume>22</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33513754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knobel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Medeiros-Neto</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Relevance of iodine intake as a reputed predisposing factor for thyroid cancer.</article-title>
            <source>Arq Bras Endocrinol Metabol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>701</fpage>
            <page-range>701-12</page-range>
            <pub-id pub-id-type="pmid">17891233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FORTNER</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>GEORGE</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>STERNBERG</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Induced and spontaneous thyroid cancer in the Syrian (golden) hamster.</article-title>
            <source>Endocrinology</source>
            <year>1960</year>
            <month>Mar</month>
            <volume>6</volume>
            <fpage>364</fpage>
            <page-range>364-76</page-range>
            <pub-id pub-id-type="pmid">13855794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avgerinos</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Spyrou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mantzoros</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Dalamaga</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Obesity and cancer risk: Emerging biological mechanisms and perspectives.</article-title>
            <source>Metabolism</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>92</volume>
            <fpage>121</fpage>
            <page-range>121-135</page-range>
            <pub-id pub-id-type="pmid">30445141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Dietary factors and the risk of thyroid cancer: a review.</article-title>
            <source>Clin Nutr Res</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-88</page-range>
            <pub-id pub-id-type="pmid">25136535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aschebrook-Kilfoy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Della Valle</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Friesen</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Occupation and thyroid cancer.</article-title>
            <source>Occup Environ Med</source>
            <year>2014</year>
            <month>May</month>
            <volume>71</volume>
            <issue>5</issue>
            <fpage>366</fpage>
            <page-range>366-80</page-range>
            <pub-id pub-id-type="pmid">24604144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>QT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Khullar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plodkowski</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of patients with thyroid cancer.</article-title>
            <source>Am Health Drug Benefits</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-40</page-range>
            <pub-id pub-id-type="pmid">25964831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roman</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>The thyroid cancer epidemic, 2017 perspective.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>332</fpage>
            <page-range>332-336</page-range>
            <pub-id pub-id-type="pmid">28692457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.</article-title>
            <source>Ann Surg</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>242</volume>
            <issue>5</issue>
            <fpage>708</fpage>
            <page-range>708-15</page-range>
            <pub-id pub-id-type="pmid">16244545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitahara</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shiels</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2020</year>
            <month>Dec</month>
            <day>01</day>
            <volume>105</volume>
            <issue>12</issue>
            <fpage>e4823</fpage>
            <page-range>e4823-30</page-range>
            <pub-id pub-id-type="pmid">32984898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Imaging for staging and management of thyroid cancer.</article-title>
            <source>Cancer Imaging</source>
            <year>2008</year>
            <month>Mar</month>
            <day>25</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-69</page-range>
            <pub-id pub-id-type="pmid">18390389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cipriani</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Nagar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Antic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sadow</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Aschebrook-Kilfoy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Angelos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?</article-title>
            <source>Thyroid</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>1209</fpage>
            <page-range>1209-16</page-range>
            <pub-id pub-id-type="pmid">26440366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zanella</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Scheffel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Weinert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dora</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review).</article-title>
            <source>Int J Oncol</source>
            <year>2021</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33649842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McHenry</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Sandoval</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Management of follicular and H&#x000fc;rthle cell neoplasms of the thyroid gland.</article-title>
            <source>Surg Oncol Clin N Am</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>893</fpage>
            <page-range>893-910</page-range>
            <pub-id pub-id-type="pmid">9735140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>743310</fpage>
            <pub-id pub-id-type="pmid">34858329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loh</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Gee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Yeo</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>82</volume>
            <issue>11</issue>
            <fpage>3553</fpage>
            <page-range>3553-62</page-range>
            <pub-id pub-id-type="pmid">9360506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forrer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Maas</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Giovanella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iakovou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Luster</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mihailovic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petranovic Ov&#x0010d;ari&#x0010d;ek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vrachimis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zerdoud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Putora</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.</article-title>
            <source>Oncology</source>
            <year>2022</year>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-81</page-range>
            <pub-id pub-id-type="pmid">34788758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raue</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Frank-Raue</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.</article-title>
            <source>Clin Cancer Res</source>
            <year>2016</year>
            <month>Oct</month>
            <day>15</day>
            <volume>22</volume>
            <issue>20</issue>
            <fpage>5012</fpage>
            <page-range>5012-5021</page-range>
            <pub-id pub-id-type="pmid">27742787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway.</article-title>
            <source>Mol Ther Oncolytics</source>
            <year>2020</year>
            <month>Mar</month>
            <day>27</day>
            <volume>16</volume>
            <fpage>124</fpage>
            <page-range>124-133</page-range>
            <pub-id pub-id-type="pmid">32055676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Rob</surname>
                <given-names>FI</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Haymart</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2022</year>
            <month>Sep</month>
            <day>28</day>
            <volume>107</volume>
            <issue>10</issue>
            <fpage>e4072</fpage>
            <page-range>e4072-e4077</page-range>
            <pub-id pub-id-type="pmid">35918064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borowczyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woli&#x00144;ski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wi&#x00119;ckowska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jod&#x00142;owska-Siewert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Szczepanek-Parulska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Verburg</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Rucha&#x00142;a</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma-A Meta-Analysis.</article-title>
            <source>Cancers (Basel)</source>
            <year>2021</year>
            <month>Feb</month>
            <day>24</day>
            <volume>13</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">33668130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruanpeng</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cheungpasitporn</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Thongprayoon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hennessey</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence.</article-title>
            <source>Endocr Pathol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-200</page-range>
            <pub-id pub-id-type="pmid">31338752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scognamiglio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Analysis of a pre-2017 follicular variant papillary thyroid carcinoma cohort reclassified as noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP): an 11-year retrospective single institution experience.</article-title>
            <source>J Am Soc Cytopathol</source>
            <year>2023</year>
            <season>Mar-Apr</season>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-119</page-range>
            <pub-id pub-id-type="pmid">36372672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mainthia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wachtel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mort</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Parangi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sadow</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Lubitz</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features.</article-title>
            <source>Surgery</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>163</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-65</page-range>
            <pub-id pub-id-type="pmid">29146229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>An artificial intelligence ultrasound system's ability to distinguish benign from malignant follicular-patterned lesions.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>981403</fpage>
            <pub-id pub-id-type="pmid">36387869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>GCH</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>KO</given-names>
              </name>
            </person-group>
            <article-title>Pathologic basis of the sonographic differences between thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features.</article-title>
            <source>Ultrasonography</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-163</page-range>
            <pub-id pub-id-type="pmid">29137452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions.</article-title>
            <source>Semin Pediatr Surg</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>150920</fpage>
            <pub-id pub-id-type="pmid">32571505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Wieneke</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Paal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Adair</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Heffess</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.</article-title>
            <source>Cancer</source>
            <year>2001</year>
            <month>Feb</month>
            <day>01</day>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>505</fpage>
            <page-range>505-24</page-range>
            <pub-id pub-id-type="pmid">11169933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asban</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lindeman</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Balentine</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kirklin</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Gender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year Experience.</article-title>
            <source>Clin Med Insights Endocrinol Diabetes</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>1179551419866196</fpage>
            <pub-id pub-id-type="pmid">31598065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors on outcomes of follicular thyroid cancer.</article-title>
            <source>J Formos Med Assoc</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>118</volume>
            <issue>7</issue>
            <fpage>1144</fpage>
            <page-range>1144-1153</page-range>
            <pub-id pub-id-type="pmid">30541677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khalid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Riaz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nawaz</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Follicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines.</article-title>
            <source>Eur Thyroid J</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>260</fpage>
            <page-range>260-5</page-range>
            <pub-id pub-id-type="pmid">26835430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillanders</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>286</fpage>
            <page-range>286-296</page-range>
            <pub-id pub-id-type="pmid">28801060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mihailovic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stefanovic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Malesevic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors.</article-title>
            <source>Cancer Biother Radiopharm</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>250</fpage>
            <page-range>250-5</page-range>
            <pub-id pub-id-type="pmid">17600472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Avanzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Treseler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ituarte</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Streja</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Greenspan</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Siperstein</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Duh</surname>
                <given-names>QY</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>OH</given-names>
              </name>
            </person-group>
            <article-title>Follicular thyroid carcinoma: histology and prognosis.</article-title>
            <source>Cancer</source>
            <year>2004</year>
            <month>Mar</month>
            <day>15</day>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>1123</fpage>
            <page-range>1123-9</page-range>
            <pub-id pub-id-type="pmid">15022277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takano</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Natural history of thyroid cancer [Review].</article-title>
            <source>Endocr J</source>
            <year>2017</year>
            <month>Mar</month>
            <day>31</day>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-244</page-range>
            <pub-id pub-id-type="pmid">28154351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21872.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahib</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Aizenberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rosenzweig</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Fleshman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Matrisian</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.</article-title>
            <source>Cancer Res</source>
            <year>2014</year>
            <month>Jun</month>
            <day>01</day>
            <volume>74</volume>
            <issue>11</issue>
            <fpage>2913</fpage>
            <page-range>2913-21</page-range>
            <pub-id pub-id-type="pmid">24840647</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
